Lan‐Lan Smith
Lan‐Lan Smith publishes mostly in Hematology, Genetics and Public Health, Environmental and Occupational Health, on topics such as Acute Myeloid Leukemia Research, Clinical practice guidelines implementation and Chronic Lymphocytic Leukemia Research.
- World rank
- #4,361,095 of 7,710,434 ranked researchers
- Rank in South Africa
- #18,921 of 29,826
- Works
- 56
- Citations
- 944
- Citations per work
- 16.9
What does Lan‐Lan Smith research?
Lan‐Lan Smith's work is mostly in Medicine (61%), Biochemistry, Genetics and Molecular Biology (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3461.3%
- Medicine3461.3%
- Everything else1629.4%
- Life Sciences59.3%
- 1Hematology23% of their works
- 2Genetics15% of their works
- 3Public Health, Environmental and Occupational Health12% of their works
- 4Molecular Biology9% of their works
- 5Oncology8% of their works
- 6Radiology, Nuclear Medicine and Imaging4% of their works
Research topics
- Acute Myeloid Leukemia Research
- Clinical practice guidelines implementation
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemophilia Treatment and Research
- Acute Lymphoblastic Leukemia research
- Lymphoma Diagnosis and Treatment
- Immunodeficiency and Autoimmune Disorders
Which keywords describe Lan‐Lan Smith's research?
The keywords of their largest research topics: Prognostic Factors, Acute Myeloid Leukemia, AML, Rituximab, Clinical Guidelines, Guideline Development, Chronic Lymphocytic Leukemia and Genomic Aberrations.
- Primary Immunodeficiency
- Lymphoma
- Hemophilia
- Childhood Cancer
- Myelofibrosis
- Genomic Aberrations
- Guideline Development
- Rituximab
- AML
- Prognostic Factors
- Acute Myeloid Leukemia
- Clinical Guidelines
- Chronic Lymphocytic Leukemia
- JAK2 Mutation
- Acute Lymphoblastic Leukemia
- Factor VIII
- Classification
- Genetic Mutations
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Prognostic Factors283 topics
- AML141 topic
- Acute Myeloid Leukemia141 topic
- Rituximab132 topics
- Clinical Guidelines101 topic
- Guideline Development101 topic
- Chronic Lymphocytic Leukemia91 topic
- Genomic Aberrations91 topic
- JAK2 Mutation81 topic
- Myelofibrosis81 topic
- Acute Lymphoblastic Leukemia51 topic
- Childhood Cancer51 topic
- Factor VIII51 topic
- Hemophilia51 topic
- Classification41 topic
- Lymphoma41 topic
- Genetic Mutations31 topic
- Primary Immunodeficiency31 topic
Where does Lan‐Lan Smith work?
Lan‐Lan Smith's main affiliation in the publication record is Lancet Laboratories, South Africa.
How many publications and citations does Lan‐Lan Smith have?
OpenAlex counts 56 works and 944 citations for Lan‐Lan Smith, an h-index of 9, ranking #4,361,095 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Lan‐Lan Smith. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.